XSOLLA
Xsolla, a global video game commerce company, announces the opening of its first Canadian office in Montreal in collaboration with GameAddik. This strategic expansion into one of North America's most dynamic tech hubs underscores Xsolla's dedication to innovation and its mission to better serve the burgeoning gaming industry and developers in Quebec and across Canada.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240808870268/en/
(Graphic: Xsolla)
Montreal has long been recognized for its dynamic gaming ecosystem and innovative tech community. By establishing a presence in this thriving city, Xsolla aims to expand its operations with incredible local talent and foster closer relationships with regional developers. The new office will serve as a hub for Xsolla's operations in Canada, enhancing its ability to offer tailored and localized solutions to its current partners and thousands of new game developers and publishers in the region.
"Montreal is renowned for its dynamic gaming ecosystem and innovative tech community. Our presence here will enable us to better support our local and global partners and tap into the incredible local talent pool," said Xsolla's president, David Stelzer. “This new office in Montreal will be crucial in strengthening our relationships with local game developers and facilitating our mission to empower our partners to reach their full potential.”
As part of this expansion, Xsolla plans to hire up to 50 regional employees over the next two years, targeting a mix of roles in business development, customer support, and technical services. This investment will strengthen its capacity to deliver cutting-edge solutions and exceptional service.
This strategic partnership with GameAddik originated from the successful cross-service opportunities explored with its dedicated marketing solution, GameRebellion, creating a robust support system for game developers in Canada.
"We are excited about our collaboration with Xsolla, as our GameRebellion project shares a common vision of empowering studios to achieve greater success," said Alain Carpentier, CTO at GameAddik.
"Our partnership with Xsolla is a game-changer for GameAddik," said Eric Jodoin, CEO of GameAddik. "Teaming up with such a prominent company allows us to better support the industry in striving for success."
The new office will be a one-stop shop for companies looking for industry-leading and cutting-edge solutions to fund, launch, market, monetize, and sell their games to local gamers and fans of their games worldwide. Xsolla provides advanced tools and services to help game developers accelerate their business by reaching players who want to pay for their gaming experiences locally using their preferred payment methods. With the ability to enable transactions in over 130 currencies and 20 languages, Xsolla has already facilitated access to new gamers for game developers worldwide.
For more information about the Xsolla Canadian office, please visit xsolla.pro/montreal.
About Xsolla
Xsolla is a global video game commerce company with a robust and powerful set of tools and services designed specifically for the industry. Since its founding in 2005, Xsolla has helped thousands of game developers and publishers of all sizes fund, market, launch, and monetize their games globally and across multiple platforms. As an innovative leader in game commerce, Xsolla’s mission is to solve the inherent complexities of global distribution, marketing, and monetization to help our partners reach more geographies, generate more revenue, and create relationships with gamers worldwide. Headquartered and incorporated in Los Angeles, California, with offices in Montreal, London, Berlin, Beijing, Guangzhou, Seoul, Tokyo, Kuala Lumpur, Raleigh, and cities around the world, Xsolla supports major gaming titles like Valve, Take-Two, KRAFTON, Nexters, NetEase, Playstudios, Playrix, miHoYo, and more.
For additional information and to learn more, please visit xsolla.com.
About GameAddik
Founded in 2015, GameAddik is an advertising technology company that provides tech-driven marketing solutions for the gaming industry. Trusted by over 200 global brands, GameAddik is a leader in understanding gaming audiences and delivering measurable performance marketing solutions for its clients across its three business segments: PWN Games (performance marketing), Elusive (performance-driven influencer marketing), and GameRebellion (game audience and industry data and analytics).
For more information, please visit gameaddik.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240808870268/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Original “Titanic Cherub” From James Cameron’s Epic Film Heads to Auction December 9 & 1024.11.2025 21:48:00 CET | Press release
Iconic Hollywood Artifact Indelibly Linked with “Jack & Rose” Portrayed by Kate Winslet and Leonardo DiCaprio One of the most recognizable and beloved set pieces from James Cameron’s Titanic heads to auction on December 9 &10 —the original Grand Staircase Cherub, seen in multiple scenes of the 1997 blockbuster, including the pivotal moment when Jack and Rose meet in front of the First Class Dining Room and the climactic moment when the Atlantic Ocean bursts through the skylight and floods the staircase, and cherub. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124056883/en/ The iconic “cherub” with Leonardo DiCaprio & Kate Winslet in James Cameron’s “TITANIC”. The ornate fixture—crafted for the full-scale recreation of Titanic’s Grand Staircase—was gifted by the production to Martin Biallas, CEO of SEE Global Entertainment, whose immersive exhibitions have brought the world’s most famous ship to millions of fans. It now
Access Advance Announces Major Growth in Its HEVC and VVC Patent Pools24.11.2025 16:10:00 CET | Press release
Access Advance LLC today announced significant expansions of both its HEVC Advance and VVC Advance Patent Pools during the second and third quarters of 2025, underscoring continued industry confidence in the company's balanced and transparent approach to video codec licensing. This growth follows the successful January 2025 launch of Access Advance's Video Distribution Patent ("VDP") Pool, demonstrating the company's expanding role in comprehensive video codec patent licensing solutions. Among the many highlights, Sharp Corporation joined the HEVC Advance Patent Pool as a Licensor, bringing valuable intellectual property assets to the pool's already extensive patent portfolio. Additionally, Huawei Technologies Co., Ltd., already an HEVC Advance Licensor and Licensee, expanded its collaboration with Access Advance by joining the VVC Advance Patent Pool as a Licensee. HP Inc. also expanded its license to include the VVC Advance Patent Pool after previously joining HEVC Advance in 2024, w
Microsize and Schedio Group to Acquire Lonza’s Micro-Macinazione Site in Switzerland24.11.2025 15:05:00 CET | Press release
Microsize, a leading CDMO specializing in particle size reduction and control technologies, today announced it has signed an agreement to acquire Micro-Macinazione (Mic Mac), a dedicated micronization facility in Monteggio, Switzerland, from Lonza. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124545344/en/ The agreement represents Microsize’s second acquisition from Lonza, following the successful 2022 divestment of its Quakertown, Pennsylvania site. In this transaction, Schedio Group – a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services – is investing alongside Microsize to strengthen and localize its operational base in Europe, advancing a shared vision to lead the next generation of integrated particle engineering solutions. With more than 30 years of experience, Mic Mac has served the pharmaceutical industry with proven GMP-compliant jet milling and micronization capabilities for b
Hytera to Debut S1 E at PMRExpo 202524.11.2025 14:17:00 CET | Press release
Hytera, a leading global provider of critical communications technologies and solutions, today introduced the S1 E, a business-ready, palm-sized two-way radio designed specifically for the retail sector, expanding the portfolio of S Series and providing one more option for retail users to choose for their daily operations. The S1 E will make its debut at PMRExpo, the Europe's premier trade fair for secure, mission- and business-critical communication, taking place from November 25th to 27th, 2025, at Koelnmesse in Cologne, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251124768341/en/ Hytera New Released Licence-free Analogue Business Radio S1 E Adhering to the S Series’ signature design language, the S1 E combines a stylish, modern, and minimalist aesthetic with practical functionality. Weighing under 85g, the S1 E provides all-day wearing comfort without tugging or weighing down uniforms. Key enhancements and sta
Merck Takes Patient-Directed Approach to Bring Innovation to the Treatment of Rare Neuromuscular Disorder, Generalized Myasthenia Gravis24.11.2025 14:00:00 CET | Press release
Cladribine capsules have the potential to be the first oral treatment for people living with rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia GravisCladribine capsules has received Fast Track designation and Orphan Drug Designation by the US FDAMerck has established an MG patient council to provide insights on how to best meet the needs of patients in the gMG rare disease community Merck, a leading science and technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for cladribine capsules for the treatment of the rare, chronic autoimmune neuromuscular disorder, generalized Myasthenia Gravis (gMG). In June 2023, the FDA granted Orphan Drug Designation for cladribine capsules for the treatment of gMG. In addition, the Company is actively collaborating with patient organizations and Ad Scientiam, a medical technology company, to support a patient-directed approach to the future management of gMG. If approved
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom